{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "clinical trials", "phytocannabinoids", "refractory epilepsy", "synthetic cannabinoids"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36556483", "DateRevised": {"Year": "2022", "Month": "12", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "15"}], "Language": ["eng"], "ELocationID": ["2117", "10.3390/life12122117"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "12", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "15"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment.", "Abstract": {"AbstractText": ["<i>Cannabis sativa</i> is one of the first medicinal plants used by humans. Its medical use remains controversial because it is a psychotropic drug whose use has been banned. Recently, however, some countries have approved its use, including for recreational and medical purposes, and have allowed the scientific study of its compounds. <i>Cannabis</i> is characterized by the production of special types of natural products called phytocannabinoids that are synthesized exclusively by this genus. Phytocannabinoids and endocannabinoids are chemically different, but both pharmacologically modulate CB1, CB2, GRP55, GRP119 and TRPV1 receptor activities, involving activities such as memory, sleep, mood, appetite and motor regulation, pain sensation, neuroinflammation, neurogenesis and apoptosis. \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD) are phytocannabinoids with greater pharmacological potential, including anti-inflammatory, neuroprotective and anticonvulsant activities. Cannabidiol is showing promising results for the treatment of COVID-19, due to its capability of acting on the unleashed cytokine storm, on the proteins necessary for both virus entry and replication and on the neurological consequences of patients who have been infected by the virus. Here, we summarize the latest knowledge regarding the advantages of using cannabinoids in the treatment of COVID-19."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Universidad de La Frontera, Temuco 4811230, Chile."}], "LastName": "P\u00e9rez", "ForeName": "Rebeca", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Instituto de Qu\u00edmica, Universidade de S\u00e3o Paulo, Av. Prof. Lineu Prestes 748, S\u00e3o Paulo 05508-000, SP, Brazil."}], "LastName": "Glaser", "ForeName": "Talita", "Initials": "T"}, {"Identifier": ["0000-0002-9066-1763"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Universidad de La Frontera, Temuco 4811230, Chile."}], "LastName": "Villegas", "ForeName": "Cecilia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad Santo Tomas, Temuco 4780000, Chile."}], "LastName": "Burgos", "ForeName": "Viviana", "Initials": "V"}, {"Identifier": ["0000-0002-2114-3815"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Instituto de Qu\u00edmica, Universidade de S\u00e3o Paulo, Av. Prof. Lineu Prestes 748, S\u00e3o Paulo 05508-000, SP, Brazil."}], "LastName": "Ulrich", "ForeName": "Henning", "Initials": "H"}, {"Identifier": ["0000-0002-4668-4984"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Universidad de La Frontera, Temuco 4811230, Chile."}], "LastName": "Paz", "ForeName": "Cristian", "Initials": "C"}], "GrantList": [{"GrantID": "2018/07366-4", "Agency": "S\u00e3o Paulo Research Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "The authors have no conflict of interest to disclose. "}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Plancarte-S\u00e1nchez R., Mansilla-Olivares A., De los Reyes-Pacheco V.A., Meneses-Gonz\u00e1lez F. Aplicaciones terap\u00e9uticas por acci\u00f3n de los cannabinoides. Gac. M\u00e9dica M\u00e9xico. 2019;155:307\u2013318.", "ArticleIdList": ["31219471"]}, {"Citation": "Covarrubias-Torres N. Uso medicinal de la Marihuana. Anest. En M\u00e9xico. 2019;31:49\u201358."}, {"Citation": "\u00c1lvarez L.G., Gomar J.J., Garc\u00eda-Portilla M.P., Bobes J. Consumo de cannabis y alteraciones cognitivas en esquizofrenia y primeros episodios psic\u00f3ticos. Adicciones. 2019;31:89\u201394. doi: 10.20882/adicciones.1328.", "ArticleIdList": ["10.20882/adicciones.1328", "31017245"]}, {"Citation": "Anil S.M., Shalev N., Vinayaka A.C., Nadarajan S., Namdar D., Belausov E., Shoval I., Mani K.A., Mechrez G., Koltai H. Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages. Sci. Rep. 2021;11:1462. doi: 10.1038/s41598-021-81049-2.", "ArticleIdList": ["10.1038/s41598-021-81049-2", "PMC7809280", "33446817"]}, {"Citation": "Du L., He Y., Zhou Y., Liu S., Zheng B.J., Jiang S. The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 2009;7:226\u2013236. doi: 10.1038/nrmicro2090.", "ArticleIdList": ["10.1038/nrmicro2090", "PMC2750777", "19198616"]}, {"Citation": "El Biali M., Broers B., Besson M., Demeules J. Cannabinoids and COVID-19. Med. Cannabis Cannabinoids. 2020;3:111\u2013115. doi: 10.1159/000510799.", "ArticleIdList": ["10.1159/000510799", "PMC7490504", "34671712"]}, {"Citation": "Esposito G., Pesce M., Seguella L., Sanseverino W., Lu J., Corpetti C., Sarnelli G. The potential of cannabidiol in the COVID-19 pandemic. Br. J. Pharm. 2020;177:4967\u20134970. doi: 10.1111/bph.15157.", "ArticleIdList": ["10.1111/bph.15157", "PMC7300643", "32519753"]}, {"Citation": "Liu D.X., Liang J.Q., Fung T.S. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae) Encycl. Virol. 2021;2:428\u2013440. doi: 10.1016/B978-0-12-809633-8.21501-X.", "ArticleIdList": ["10.1016/B978-0-12-809633-8.21501-X"]}, {"Citation": "Lucaciu O., Aghiorghiesei O., Petrescu N.B., Mirica I.C., Benea H.R.C., Apostu D. In quest of a new therapeutic approach in COVID-19: The endocannabinoid system. Drug Metab. Rev. 2021;53:478\u2013490. doi: 10.1080/03602532.2021.1895204.", "ArticleIdList": ["10.1080/03602532.2021.1895204", "PMC7989954", "33683968"]}, {"Citation": "Devinsky O., Cilio M.R., Cross H., Fernandez-Ruiz J., French J., Hill C., Katz R., Di Marzo V., Jutras-Aswad D., Notcutt W.G. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014;55:791\u2013802. doi: 10.1111/epi.12631.", "ArticleIdList": ["10.1111/epi.12631", "PMC4707667", "24854329"]}, {"Citation": "Galzerano Guida J., Orellana Navone C., P\u00e9rez R., Coiti\u00f1o Gonz\u00e1lez A., Vel\u00e1zquez Ramos P. Medicinal Cannabis as a therapeutic resource: Preliminary study. Rev. Med. Del Urug. 2019;35:113\u2013137, 289\u2013297."}, {"Citation": "Kirkham T. Endocannabinoids in the regulation of appetite and body weight. Behav. Pharmacol. 2005;16:297\u2013313. doi: 10.1097/00008877-200509000-00004.", "ArticleIdList": ["10.1097/00008877-200509000-00004", "16148436"]}, {"Citation": "Maldonado R., Berrendero F. Endogenous cannabinoid and opioid systems and their role in nicotine addiction. Curr. Drug Targets. 2010;11:440\u2013449. doi: 10.2174/138945010790980358.", "ArticleIdList": ["10.2174/138945010790980358", "20017727"]}, {"Citation": "Parsons L.H., Hurd Y.L. Endocannabinoid signalling in reward and addiction. Nat. Rev. Neurosci. 2015;16:579\u2013594. doi: 10.1038/nrn4004.", "ArticleIdList": ["10.1038/nrn4004", "PMC4652927", "26373473"]}, {"Citation": "Devane W.A., Hanu\u0161 L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258:1946\u20131949. doi: 10.1126/science.1470919.", "ArticleIdList": ["10.1126/science.1470919", "1470919"]}, {"Citation": "Di Marzo V., De Petrocellis L. Why do cannabinoid receptors have more than one endogenous ligand? Philos. Trans. R. Soc. B Biol. Sci. 2012;367:3216\u20133228. doi: 10.1098/rstb.2011.0382.", "ArticleIdList": ["10.1098/rstb.2011.0382", "PMC3481524", "23108541"]}, {"Citation": "Karhson D.S., Krasinska K.M., Dallaire J.A., Libove R.A., Phillips J.M., Chien A.S., Garner J.P., Hardan A.Y., Parker K.J. Plasma anandamide concentrations are lower in children with autism spectrum disorder. Mol. Autism. 2018;9:1\u20136. doi: 10.1186/s13229-018-0203-y.", "ArticleIdList": ["10.1186/s13229-018-0203-y", "PMC5848550", "29564080"]}, {"Citation": "Mayo L.M., Asratian A., Lind\u00e9 J., Holm L., N\u00e4tt D., Augier G., Stensson N., Vecchiarelli H.A., Balsevich G., Aukema R.J. Protective effects of elevated anandamide on stress and fear-related behaviors: Translational evidence from humans and mice. Mol. Psychiatry. 2020;25:993\u20131005. doi: 10.1038/s41380-018-0215-1.", "ArticleIdList": ["10.1038/s41380-018-0215-1", "30120421"]}, {"Citation": "Mayo L.M., Asratian A., Lind\u00e9 J., Morena M., Haataja R., Hammar V., Augier G., Hill M.N., Heilig M. Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: A randomized, controlled experimental medicine trial. Biol. Psychiatry. 2020;87:538\u2013547. doi: 10.1016/j.biopsych.2019.07.034.", "ArticleIdList": ["10.1016/j.biopsych.2019.07.034", "31590924"]}, {"Citation": "Spohrs J., Ulrich M., Gr\u00f6n G., Prost M., Plener P.L., Fegert J.M., Bindila L., Abler B. Fear extinction learning and anandamide: An fMRI study in healthy humans. Transl. Psychiatry. 2021;11:161. doi: 10.1038/s41398-020-01177-7.", "ArticleIdList": ["10.1038/s41398-020-01177-7", "PMC7961038", "33723207"]}, {"Citation": "Correia-S\u00e1 I.B., Carvalho C.M., Serr\u00e3o P.V., Loureiro A.I., Fernandes-Lopes C., Marques M., Vieira-Coelho M.A. A new role for anandamide: Defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing. Sci. Rep. 2020;10:11134. doi: 10.1038/s41598-020-68058-3.", "ArticleIdList": ["10.1038/s41598-020-68058-3", "PMC7341842", "32636441"]}, {"Citation": "Zygmunt P.M., Ermund A., Movahed P., Andersson D.A., Simonsen C., J\u00f6nsson B.A., Blomgren A., Birnir B., Bevan S., Eschalier A., et al. Monoacylglycerols activate TRPV1-a link between phospholipase C and TRPV1. PLoS ONE. 2013;8:e81618. doi: 10.1371/journal.pone.0081618.", "ArticleIdList": ["10.1371/journal.pone.0081618", "PMC3847081", "24312564"]}, {"Citation": "Rodriguez C.G. Editor From Cannabis to the Endogenous Cannabinoid System: New Perspectives in Neuroinflammation. Annals of the Royal Academy of Doctors of Spain.  [(accessed on 10 September 2022)].  2018, 3, 379\u2013393. Available online:  https://wwwpublicacionesradees/indexphp/arade/article/view/93/72."}, {"Citation": "Turcotte C., Archambault A.S., Dumais \u00c9., Martin C., Blanchet M.R., Bissonnette E., Ohashi N., Yamamoto K., Itoh T., Laviolette M. Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes. FASEB J. 2020;34:4253\u20134265. doi: 10.1096/fj.201902916R.", "ArticleIdList": ["10.1096/fj.201902916R", "32012340"]}, {"Citation": "Prosp\u00e9ro Garc\u00eda O.E., Ruiz Contreras A.E., Cort\u00e9s Morelos J., Herrera Sol\u00eds A., M\u00e9ndez D\u00edaz M. Marihuana: Legalization and Medical Care. Rev. De La Fac. De Med. 2019;62:6\u201323. doi: 10.22201/fm.24484865e.2019.62.6.02.", "ArticleIdList": ["10.22201/fm.24484865e.2019.62.6.02"]}, {"Citation": "Ra\u00efch I., Rivas-Santisteban R., Lillo A., Lillo J., Reyes-Resina I., Nadal X., Ferreiro-Vera C., de Medina V.S., Majellaro M., Sotelo E., et al. Similarities and differences upon binding of naturally occurring \u0394(9)-tetrahydrocannabinol-derivatives to cannabinoid CB(1) and CB(2) receptors. Pharmacol. Res. 2021;174:105970. doi: 10.1016/j.phrs.2021.105970.", "ArticleIdList": ["10.1016/j.phrs.2021.105970", "34758399"]}, {"Citation": "Olianas M.C., Dedoni S., Onali P. Cannabinoid CB(1) and CB(2) receptors differentially regulate TNF-\u03b1-induced apoptosis and LPA(1)-mediated pro-survival signaling in HT22 hippocampal cells. Life Sci. 2021;276:119407. doi: 10.1016/j.lfs.2021.119407.", "ArticleIdList": ["10.1016/j.lfs.2021.119407", "33794254"]}, {"Citation": "K\u00f6falvi A., Moreno E., Cordom\u00ed A., Cai N.S., Fern\u00e1ndez-Due\u00f1as V., Ferreira S.G., Guix\u00e0-Gonz\u00e1lez R., S\u00e1nchez-Soto M., Yano H., Casad\u00f3-Anguera V., et al. Control of glutamate release by complexes of adenosine and cannabinoid receptors. BMC Biol. 2020;18:9. doi: 10.1186/s12915-020-0739-0.", "ArticleIdList": ["10.1186/s12915-020-0739-0", "PMC6979073", "31973708"]}, {"Citation": "Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: An overview. Int. J. Obes. 2006;30:S13\u2013S18. doi: 10.1038/sj.ijo.0803272.", "ArticleIdList": ["10.1038/sj.ijo.0803272", "16570099"]}, {"Citation": "Malik A., Fatehi K.S., Menon N.N., Chaturvedi P. Review of Medicinal Use of Cannabis Derivatives and the Societal Impact of Legalization. Indian J. Palliat. Care. 2020;26:369\u2013380. doi: 10.4103/IJPC.IJPC_19_20.", "ArticleIdList": ["10.4103/IJPC.IJPC_19_20", "PMC7725166", "33311882"]}, {"Citation": "Ceni C., Benko M.J., Mohamed K.A., Poli G., Di Stefano M., Tuccinardi T., Digiacomo M., Valoti M., Laprairie R.B., Macchia M., et al. Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold. Pharmaceuticals. 2022;15:768. doi: 10.3390/ph15070768.", "ArticleIdList": ["10.3390/ph15070768", "PMC9320067", "35890067"]}, {"Citation": "Johns D., Behm D., Walker D., Ao Z., Shapland E., Daniels D., Riddick M., Dowell S., Staton P., Green P. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br. J. Pharmacol. 2007;152:825\u2013831. doi: 10.1038/sj.bjp.0707419.", "ArticleIdList": ["10.1038/sj.bjp.0707419", "PMC2190033", "17704827"]}, {"Citation": "Whyte L.S., Ryberg E., Sims N.A., Ridge S.A., Mackie K., Greasley P.J., Ross R.A., Rogers M.J. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc. Natl. Acad. Sci. USA. 2009;106:16511\u201316516. doi: 10.1073/pnas.0902743106.", "ArticleIdList": ["10.1073/pnas.0902743106", "PMC2737440", "19805329"]}, {"Citation": "Henstridge C.M., Balenga N.A., Ford L.A., Ross R.A., Waldhoer M., Irving A.J. The GPR55 ligand L-\u03b1-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J. 2009;23:183\u2013193. doi: 10.1096/fj.08-108670.", "ArticleIdList": ["10.1096/fj.08-108670", "18757503"]}, {"Citation": "Henstridge C.M., Balenga N.A., Schr\u00f6der R., Kargl J.K., Platzer W., Martini L., Arthur S., Penman J., Whistler J.L., Kostenis E. GPR55 ligands promote receptor coupling to multiple signalling pathways. Br. J. Pharmacol. 2010;160:604\u2013614. doi: 10.1111/j.1476-5381.2009.00625.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00625.x", "PMC2931561", "20136841"]}, {"Citation": "Lauckner J.E., Jensen J.B., Chen H.-Y., Lu H.-C., Hille B., Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl. Acad. Sci. USA. 2008;105:2699\u20132704. doi: 10.1073/pnas.0711278105.", "ArticleIdList": ["10.1073/pnas.0711278105", "PMC2268199", "18263732"]}, {"Citation": "Brown A. Novel cannabinoid receptors. Br. J. Pharmacol. 2007;152:567\u2013575. doi: 10.1038/sj.bjp.0707481.", "ArticleIdList": ["10.1038/sj.bjp.0707481", "PMC2190013", "17906678"]}, {"Citation": "Reddy D.S., Golub V.M. The pharmacological basis of cannabis therapy for epilepsy. J. Pharmacol. Exp. Ther. 2016;357:45\u201355. doi: 10.1124/jpet.115.230151.", "ArticleIdList": ["10.1124/jpet.115.230151", "26787773"]}, {"Citation": "Maccarrone M., Lorenzon T., Bari M., Melino G., Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors: Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 2000;275:31938\u201331945. doi: 10.1074/jbc.M005722200.", "ArticleIdList": ["10.1074/jbc.M005722200", "10913156"]}, {"Citation": "Brown J.D. Potential adverse drug events with tetrahydrocannabinol (THC) due to drug\u2013drug interactions. J. Clin. Med. 2020;9:919. doi: 10.3390/jcm9040919.", "ArticleIdList": ["10.3390/jcm9040919", "PMC7231229", "32230864"]}, {"Citation": "Maroon J., Bost J. Review of the neurological benefits of phytocannabinoids. Surg. Neurol. Int. 2018;9:91. doi: 10.4103/sni.sni_45_18.", "ArticleIdList": ["10.4103/sni.sni_45_18", "PMC5938896", "29770251"]}, {"Citation": "Mead A. The legal status of cannabis (marijuana) and cannabidiol (CBD) under US law. Epilepsy Behav. 2017;70:288\u2013291. doi: 10.1016/j.yebeh.2016.11.021.", "ArticleIdList": ["10.1016/j.yebeh.2016.11.021", "28169144"]}, {"Citation": "Suero-Garc\u00eda C., Mart\u00edn-Banderas L., Holgado M. Efecto neuroprotector de los cannabinoides en las enfermedades neurodegenerativas. Ars Pharm. 2015;56:77\u201387. doi: 10.4321/S2340-98942015000200002.", "ArticleIdList": ["10.4321/S2340-98942015000200002"]}, {"Citation": "U.S. Food & Drug Administration Fel  Marinol\u00ae Data Sheet or Summary of Product Characteristics 06/12/2017.  [(accessed on 10 September 2022)]; Available online:  https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf."}, {"Citation": "Gloss D. An overview of products and bias in research. Neurotherapeutics. 2015;12:731\u2013734. doi: 10.1007/s13311-015-0370-x.", "ArticleIdList": ["10.1007/s13311-015-0370-x", "PMC4604179", "26202343"]}, {"Citation": "Grotenhermen F., M\u00fcller-Vahl K. Medicinal uses of marijuana and cannabinoids. Crit. Rev. Plant Sci. 2016;35:378\u2013405. doi: 10.1080/07352689.2016.1265360.", "ArticleIdList": ["10.1080/07352689.2016.1265360"]}, {"Citation": "Gover J. Sativex 2.7 mg/2.5 mg Oral Spray Solution. GW Pharma Ltd. 2018.  [(accessed on 25 July 2021)].  Available online:  https://cima.aemps.es/cima/dochtml/ft/72544/FT_72544.html."}, {"Citation": "Abu-Sawwa R., Scutt B., Park Y. Emerging use of epidiolex (cannabidiol) in epilepsy. J. Pediatr. Pharmacol. Ther. 2020;25:485\u2013499. doi: 10.5863/1551-6776-25.6.485.", "ArticleIdList": ["10.5863/1551-6776-25.6.485", "PMC7439947", "32839652"]}, {"Citation": "Custodio N. Peruvian patients use cannabidiol for refractory epilepsy: Apropos of the evidence-based indication of marijuana-derived products. J. Neuro-Psychiatry. 2019;82:101\u2013103."}, {"Citation": "Antonio L., De Los Milagros P. Marihuana Medicinal en el Tratamiento de la Epilepsia. Rev. M\u00e9dica Hosp. Hip\u00f3lito Unanue Tacna. 2018;11:38\u201342."}, {"Citation": "Blessing E.M., Steenkamp M.M., Manzanares J., Marmar C.R. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12:825\u2013836. doi: 10.1007/s13311-015-0387-1.", "ArticleIdList": ["10.1007/s13311-015-0387-1", "PMC4604171", "26341731"]}, {"Citation": "Cross J.H., Devinsky O., Marsh E., Miller I., Nabbout R., Scheffer I.E., Thiele E.A., Laux L., Wright S. Cannabidiol (CBD) Reduces Convulsive Seizure Frequency in Dravet Syndrome: Results of a Multi-Center, Randomized, Controlled Trial (GWPCARE1)(CT. 001) AAN Enterprises; Barcelona, Espa\u00f1a: 2017.", "ArticleIdList": ["10.1111/epi.13944"]}, {"Citation": "Fern\u00e1ndez-Ruiz J., Sagredo O., Pazos M.R., Garc\u00eda C., Pertwee R., Mechoulam R., Mart\u00ednez-Orgado J. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid? Br. J. Clin. Pharmacol. 2013;75:323\u2013333. doi: 10.1111/j.1365-2125.2012.04341.x.", "ArticleIdList": ["10.1111/j.1365-2125.2012.04341.x", "PMC3579248", "22625422"]}, {"Citation": "Rajan T.S., Giacoppo S., Iori R., De Nicola G.R., Grassi G., Pollastro F., Bramanti P., Mazzon E. Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages. Fitoterapia. 2016;112:104\u2013115. doi: 10.1016/j.fitote.2016.05.008.", "ArticleIdList": ["10.1016/j.fitote.2016.05.008", "27215129"]}, {"Citation": "Rizzo M.D., Crawford R.B., Henriquez J.E., Aldhamen Y.A., Gulick P., Amalfitano A., Kaminski N.E. HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-\u03b3-inducible protein 10 levels compared with nonusing HIV patients. Aids. 2018;32:419\u2013429. doi: 10.1097/QAD.0000000000001704.", "ArticleIdList": ["10.1097/QAD.0000000000001704", "PMC5790621", "29194121"]}, {"Citation": "Herrera-V\u00e1zquez O., Rojas A.T., Fleury A. Neuroinflammation and epilepsy. TIP J. Spec. Chem. Biol. Sci. 2016;19:24\u201331."}, {"Citation": "Fern\u00e1ndez-Ruiz J., Garc\u00eda C., Sagredo O., G\u00f3mez-Ruiz M., de Lago E. The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opin. Ther. Targets. 2010;14:387\u2013404. doi: 10.1517/14728221003709792.", "ArticleIdList": ["10.1517/14728221003709792", "20230193"]}, {"Citation": "Kaplan J.S., Stella N., Catterall W.A., Westenbroek R.E. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc. Natl. Acad. Sci. USA. 2017;114:11229\u201311234. doi: 10.1073/pnas.1711351114.", "ArticleIdList": ["10.1073/pnas.1711351114", "PMC5651774", "28973916"]}, {"Citation": "Devinsky O., Patel A.D., Cross J.H., Villanueva V., Wirrell E.C., Privitera M., Greenwood S.M., Roberts C., Checketts D., VanLandingham K.E. Effect of cannabidiol on drop seizures in the Lennox\u2013Gastaut syndrome. N. Engl. J. Med. 2018;378:1888\u20131897. doi: 10.1056/NEJMoa1714631.", "ArticleIdList": ["10.1056/NEJMoa1714631", "29768152"]}, {"Citation": "Thiele E.A., Marsh E.D., French J.A., Mazurkiewicz-Beldzinska M., Benbadis S.R., Joshi C., Lyons P.D., Taylor A., Roberts C., Sommerville K. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391:1085\u20131096. doi: 10.1016/S0140-6736(18)30136-3.", "ArticleIdList": ["10.1016/S0140-6736(18)30136-3", "29395273"]}, {"Citation": "Devinsky O., Patel A.D., Thiele E.A., Wong M.H., Appleton R., Harden C.L., Greenwood S., Morrison G., Sommerville K., Group G.P.A.S. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome. Neurology. 2018;90:e1204\u2013e1211. doi: 10.1212/WNL.0000000000005254.", "ArticleIdList": ["10.1212/WNL.0000000000005254", "PMC5890607", "29540584"]}, {"Citation": "Devinsky O., Cross J.H., Laux L., Marsh E., Miller I., Nabbout R., Scheffer I.E., Thiele E.A., Wright S. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N. Engl. J. Med. 2017;376:2011\u20132020. doi: 10.1056/NEJMoa1611618.", "ArticleIdList": ["10.1056/NEJMoa1611618", "28538134"]}, {"Citation": "Szaflarski J.P., Bebin E.M., Cutter G., DeWolfe J., Dure L.S., Gaston T.E., Kankirawatana P., Liu Y., Singh R., Standaert D.G. Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study. Epilepsy Behav. 2018;87:131\u2013136. doi: 10.1016/j.yebeh.2018.07.020.", "ArticleIdList": ["10.1016/j.yebeh.2018.07.020", "30100226"]}, {"Citation": "Kara\u017aniewicz-\u0141ada M., G\u0142\u00f3wka A.K., Mikulska A.A., G\u0142\u00f3wka F.K. Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients. Int. J. Mol. Sci. 2021;22:9582. doi: 10.3390/ijms22179582.", "ArticleIdList": ["10.3390/ijms22179582", "PMC8431452", "34502487"]}, {"Citation": "OMS  Panel de Control de la Enfermedad por Coronavirus (COVID-19) [En L\u00ednea] 2022.  [(accessed on 18 May 2022)].  Available online:  https://covid19.who.int/"}, {"Citation": "Costiniuk C.T., Jenabian M.A. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment? Cytokine Growth Factor Rev. 2020;53:63\u201365. doi: 10.1016/j.cytogfr.2020.05.008.", "ArticleIdList": ["10.1016/j.cytogfr.2020.05.008", "PMC7239000", "32467020"]}, {"Citation": "Almogi-Hazan O., Or R. Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back. Int. J. Mol. Sci. 2020;21:4448. doi: 10.3390/ijms21124448.", "ArticleIdList": ["10.3390/ijms21124448", "PMC7352399", "32585801"]}, {"Citation": "Rizzo M.D., Henriquez J.E., Blevins L.K., Bach A., Crawford R.B., Kaminski N.E. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder. J. Neuroimmune Pharmacol. 2020;15:780\u2013793. doi: 10.1007/s11481-020-09918-7.", "ArticleIdList": ["10.1007/s11481-020-09918-7", "PMC7666101", "32409991"]}, {"Citation": "Rossi F., Tortora C., Argenziano M., Di Paola A., Punzo F. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Int. J. Mol. Sci. 2020;21:3809. doi: 10.3390/ijms21113809.", "ArticleIdList": ["10.3390/ijms21113809", "PMC7312493", "32471272"]}, {"Citation": "Salles \u00c9.L., Khodadadi H., Jarrahi A., Ahluwalia M., Paffaro V.A., Jr., Costigliola V., Yu J.C., Hess D.C., Dhandapani K.M., Baban B. Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome. J. Cell. Mol. Med. 2020;24:12869\u201312872. doi: 10.1111/jcmm.15883.", "ArticleIdList": ["10.1111/jcmm.15883", "PMC7686987", "33058425"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271\u2013280.e278. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Manuzak J.A., Gott T.M., Kirkwood J.S., Coronado E., Hensley-McBain T., Miller C., Cheu R.K., Collier A.C., Funderburg N.T., Martin J.N., et al. Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2018;66:1872\u20131882. doi: 10.1093/cid/cix1116.", "ArticleIdList": ["10.1093/cid/cix1116", "PMC6248381", "29471387"]}, {"Citation": "Park M.D. Macrophages: A Trojan horse in COVID-19? Nat. Rev. Immunol. 2020;20:351. doi: 10.1038/s41577-020-0317-2.", "ArticleIdList": ["10.1038/s41577-020-0317-2", "PMC7186930", "32303696"]}, {"Citation": "Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 2020;526:135\u2013140. doi: 10.1016/j.bbrc.2020.03.044.", "ArticleIdList": ["10.1016/j.bbrc.2020.03.044", "PMC7156119", "32199615"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Hasenberg M., Stegemann-Koniszewski S., Gunzer M. Cellular immune reactions in the lung. Immunol. Rev. 2013;251:189\u2013214. doi: 10.1111/imr.12020.", "ArticleIdList": ["10.1111/imr.12020", "23278750"]}, {"Citation": "Hussell T., Bell T.J. Alveolar macrophages: Plasticity in a tissue-specific context. Nat. Rev. Immunol. 2014;14:81\u201393. doi: 10.1038/nri3600.", "ArticleIdList": ["10.1038/nri3600", "24445666"]}, {"Citation": "Vardhana S.A., Wolchok J.D. The many faces of the anti-COVID immune response. J. Exp. Med. 2020;217:e20200678. doi: 10.1084/jem.20200678.", "ArticleIdList": ["10.1084/jem.20200678", "PMC7191310", "32353870"]}, {"Citation": "Xiong Y., Liu Y., Cao L., Wang D., Guo M., Jiang A., Guo D., Hu W., Yang J., Tang Z., et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg. Microbes Infect. 2020;9:761\u2013770. doi: 10.1080/22221751.2020.1747363.", "ArticleIdList": ["10.1080/22221751.2020.1747363", "PMC7170362", "32228226"]}, {"Citation": "Zhou Z., Ren L., Zhang L., Zhong J., Xiao Y., Jia Z., Guo L., Yang J., Wang C., Jiang S., et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. Cell Host Microbe. 2020;27:883\u2013890.e882. doi: 10.1016/j.chom.2020.04.017.", "ArticleIdList": ["10.1016/j.chom.2020.04.017", "PMC7196896", "32407669"]}, {"Citation": "Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620\u20132629. doi: 10.1172/JCI137244.", "ArticleIdList": ["10.1172/JCI137244", "PMC7190990", "32217835"]}, {"Citation": "Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N., Damoraki G., Gkavogianni T., Adami M.E., Katsaounou P., et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe. 2020;27:992\u20131000.e1003. doi: 10.1016/j.chom.2020.04.009.", "ArticleIdList": ["10.1016/j.chom.2020.04.009", "PMC7172841", "32320677"]}, {"Citation": "Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., Zhou Y., Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 2020;17:613\u2013620. doi: 10.1038/s41423-020-0400-4.", "ArticleIdList": ["10.1038/s41423-020-0400-4", "PMC7091888", "32203189"]}, {"Citation": "Daniloski Z., Jordan T.X., Wessels H.H., Hoagland D.A., Kasela S., Legut M., Maniatis S., Mimitou E.P., Lu L., Geller E., et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Cell. 2021;184:92\u2013105.e116. doi: 10.1016/j.cell.2020.10.030.", "ArticleIdList": ["10.1016/j.cell.2020.10.030", "PMC7584921", "33147445"]}, {"Citation": "Schneider W.M., Luna J.M., Hoffmann H.H., S\u00e1nchez-Rivera F.J., Leal A.A., Ashbrook A.W., Le Pen J., Ricardo-Lax I., Michailidis E., Peace A., et al. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks. Cell. 2021;184:120\u2013132.e114. doi: 10.1016/j.cell.2020.12.006.", "ArticleIdList": ["10.1016/j.cell.2020.12.006", "PMC7796900", "33382968"]}, {"Citation": "Wang R., Simoneau C.R., Kulsuptrakul J., Bouhaddou M., Travisano K.A., Hayashi J.M., Carlson-Stevermer J., Zengel J.R., Richards C.M., Fozouni P., et al. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. Cell. 2021;184:106\u2013119.e114. doi: 10.1016/j.cell.2020.12.004.", "ArticleIdList": ["10.1016/j.cell.2020.12.004", "PMC7723770", "33333024"]}, {"Citation": "Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J., Tan K.S., Wang D.Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2014an update on the status. Mil. Med. Res. 2020;7:11. doi: 10.1186/s40779-020-00240-0.", "ArticleIdList": ["10.1186/s40779-020-00240-0", "PMC7068984", "32169119"]}, {"Citation": "Jiang S., Hillyer C., Du L. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. Trends Immunol. 2020;41:355\u2013359. doi: 10.1016/j.it.2020.03.007.", "ArticleIdList": ["10.1016/j.it.2020.03.007", "PMC7129017", "32249063"]}, {"Citation": "Tahamtan A., Tavakoli-Yaraki M., Salimi V. Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients. Expert Rev. Respir. Med. 2020;14:965\u2013967. doi: 10.1080/17476348.2020.1787836.", "ArticleIdList": ["10.1080/17476348.2020.1787836", "PMC7441794", "32576053"]}, {"Citation": "Erukainure O.L., Matsabisa M.G., Muhammad A., Abarshi M.M., Amaku J.F., Katsayal S.B., Nde A.L. Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L. Front. Pharmacol. 2021;12:736511. doi: 10.3389/fphar.2021.736511.", "ArticleIdList": ["10.3389/fphar.2021.736511", "PMC8448283", "34539415"]}, {"Citation": "Ulbricht T.L.V. Purines, Pyrimidines and Nucleotides and the Chemistry of Nucleic Acids. Elsevier; Amsterdam, The Netherlands: 2016."}, {"Citation": "Attia Y.A., Alagawany M.M., Farag M.R., Alkhatib F.M., Khafaga A.F., Abdel-Moneim A.E., Asiry K.A., Mesalam N.M., Shafi M.E., Al-Harthi M.A., et al. Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus. Front. Vet. Sci. 2020;7:573159. doi: 10.3389/fvets.2020.573159.", "ArticleIdList": ["10.3389/fvets.2020.573159", "PMC7606864", "33195565"]}, {"Citation": "Khanna K., Kohli S.K., Kaur R., Bhardwaj A., Bhardwaj V., Ohri P., Sharma A., Ahmad A., Bhardwaj R., Ahmad P. Herbal immune-boosters: Substantial warriors of pandemic COVID-19 battle. Phytomed. Int. J. Phytother. Phytopharm. 2021;85:153361. doi: 10.1016/j.phymed.2020.153361.", "ArticleIdList": ["10.1016/j.phymed.2020.153361", "PMC7532351", "33485605"]}, {"Citation": "Asai A., Konno M., Ozaki M., Otsuka C., Vecchione A., Arai T., Kitagawa T., Ofusa K., Yabumoto M., Hirotsu T., et al. COVID-19 Drug Discovery Using Intensive Approaches. Int. J. Mol. Sci. 2020;21:2839. doi: 10.3390/ijms21082839.", "ArticleIdList": ["10.3390/ijms21082839", "PMC7215413", "32325767"]}, {"Citation": "Peng M. Outbreak of COVID-19: An emerging global pandemic threat. Biomed. Pharmacother. = Biomed. Pharmacother. 2020;129:110499. doi: 10.1016/j.biopha.2020.110499.", "ArticleIdList": ["10.1016/j.biopha.2020.110499", "PMC7334916", "32768974"]}, {"Citation": "Tu Y.F., Chien C.S., Yarmishyn A.A., Lin Y.Y., Luo Y.H., Lin Y.T., Lai W.Y., Yang D.M., Chou S.J., Yang Y.P., et al. A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Int. J. Mol. Sci. 2020;21:2657. doi: 10.3390/ijms21072657.", "ArticleIdList": ["10.3390/ijms21072657", "PMC7177898", "32290293"]}, {"Citation": "Weisberg E., Sattler M., Yang P.L., Parent A., Gray N., Griffin J.D. Current therapies under investigation for COVID-19: Potential COVID-19 treatments. Can. J. Physiol. Pharmacol. 2020;98:483\u2013489. doi: 10.1139/cjpp-2020-0286.", "ArticleIdList": ["10.1139/cjpp-2020-0286", "32640179"]}, {"Citation": "Nguyen L.C., Yang D., Nicolaescu V., Best T.J., Ohtsuki T., Chen S.N., Friesen J.B., Drayman N., Mohamed A., Dann C., et al. Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response. bioRxiv. 2021 doi: 10.1101/2021.03.10.432967.", "ArticleIdList": ["10.1101/2021.03.10.432967", "35050692"]}, {"Citation": "Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., M\u00f8ller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181:1036\u20131045.e1039. doi: 10.1016/j.cell.2020.04.026.", "ArticleIdList": ["10.1016/j.cell.2020.04.026", "PMC7227586", "32416070"]}, {"Citation": "Haller O., Kochs G., Weber F. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology. 2006;344:119\u2013130. doi: 10.1016/j.virol.2005.09.024.", "ArticleIdList": ["10.1016/j.virol.2005.09.024", "PMC7125643", "16364743"]}, {"Citation": "Food and Drug Administration . Clinical Pharmacology and Biopharmaceutical Reviews. FDA; Silver Spring, MD, USA: 2017. Application Number 210365Orig1s000."}, {"Citation": "Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z., Lu G., Qiao C., Hu Y., Yuen K.Y., et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020;181:894\u2013904.e899. doi: 10.1016/j.cell.2020.03.045.", "ArticleIdList": ["10.1016/j.cell.2020.03.045", "PMC7144619", "32275855"]}, {"Citation": "van Breemen R.B., Muchiri R.N., Bates T.A., Weinstein J.B., Leier H.C., Farley S., Tafesse F.G. Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants. J. Nat. Prod. 2022;85:176\u2013184. doi: 10.1021/acs.jnatprod.1c00946.", "ArticleIdList": ["10.1021/acs.jnatprod.1c00946", "PMC8768006", "35007072"]}, {"Citation": "Raj V., Park J.G., Cho K.H., Choi P., Kim T., Ham J., Lee J. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches. Int. J. Biol. Macromol. 2021;168:474\u2013485. doi: 10.1016/j.ijbiomac.2020.12.020.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.12.020", "PMC7836687", "33290767"]}, {"Citation": "Muus C., Luecken M.D., Eraslan G., Waghray A., Heimberg G., Sikkema L., Kobayashi Y., Vaishnav E.D., Subramanian A., Smilie C., et al. Integrated single-cell atlas analyses reveal associations of age, gender, and smoking with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlight inflammatory programs in putative target cells. bioRxiv. 2020 doi: 10.1101/2020.04.19.049254.", "ArticleIdList": ["10.1101/2020.04.19.049254"]}, {"Citation": "Malinowska B., Baranowska-Kuczko M., Kicman A., Schlicker E. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int. J. Mol. Sci. 2021;22:1986. doi: 10.3390/ijms22041986.", "ArticleIdList": ["10.3390/ijms22041986", "PMC7922403", "33671463"]}, {"Citation": "Wang B., Kovalchuk A., Li D., Rodriguez-Juarez R., Ilnytskyy Y., Kovalchuk I., Kovalchuk O. In search of preventive strategies: Novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging. 2020;12:22425\u201322444. doi: 10.18632/aging.202225.", "ArticleIdList": ["10.18632/aging.202225", "PMC7746344", "33221759"]}, {"Citation": "Wang B., Li D., Fiselier A., Kovalchuk I., Kovalchuk O. New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts. Cell Death Discov. 2022;8:110. doi: 10.1038/s41420-022-00876-y.", "ArticleIdList": ["10.1038/s41420-022-00876-y", "PMC8913855", "35277472"]}, {"Citation": "Saraswat A., Vartak R., Patki M., Patel K. Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment. Cannabis Cannabinoid Res. 2021 doi: 10.1089/can.2021.0109. Epub ahead of print .", "ArticleIdList": ["10.1089/can.2021.0109", "34918945"]}, {"Citation": "Sarafian T., Montes C., Harui A., Beedanagari S.R., Kiertscher S., Stripecke R., Hossepian D., Kitchen C., Kern R., Belperio J., et al. Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cells. Toxicol. Appl. Pharmacol. 2008;231:282\u2013290. doi: 10.1016/j.taap.2008.05.001.", "ArticleIdList": ["10.1016/j.taap.2008.05.001", "PMC2615389", "18556036"]}, {"Citation": "Janecki M., Graczyk M., Lewandowska A.A., Pawlak \u0141. Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection. Int. J. Mol. Sci. 2022;23:4170. doi: 10.3390/ijms23084170.", "ArticleIdList": ["10.3390/ijms23084170", "PMC9025270", "35456990"]}, {"Citation": "Nichols J.M., Kaplan B.L.F. Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res. 2020;5:12\u201331. doi: 10.1089/can.2018.0073.", "ArticleIdList": ["10.1089/can.2018.0073", "PMC7173676", "32322673"]}, {"Citation": "Gertsch J. Editorial: Lung macrophages high on cannabinoids: Jamming PAMs and taming TAMs? J. Leukoc. Biol. 2016;99:518\u2013520. doi: 10.1189/jlb.3CE0915-409RR.", "ArticleIdList": ["10.1189/jlb.3CE0915-409RR", "27034462"]}, {"Citation": "Mechoulam R., Peters M., Murillo-Rodriguez E., Hanus L.O. Cannabidiol\u2013recent advances. Chem. Biodivers. 2007;4:1678\u20131692. doi: 10.1002/cbdv.200790147.", "ArticleIdList": ["10.1002/cbdv.200790147", "17712814"]}, {"Citation": "Kovalchuk A., Wang B., Li D., Rodriguez-Juarez R., Ilnytskyy S., Kovalchuk I., Kovalchuk O. Fighting the storm: Could novel anti-TNF\u03b1 and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19? Aging. 2021;13:1571\u20131590. doi: 10.18632/aging.202500.", "ArticleIdList": ["10.18632/aging.202500", "PMC7880317", "33465050"]}, {"Citation": "Vuolo F., Abreu S.C., Michels M., Xisto D.G., Blanco N.G., Hallak J.E., Zuardi A.W., Crippa J.A., Reis C., Bahl M., et al. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. Eur. J. Pharmacol. 2019;843:251\u2013259. doi: 10.1016/j.ejphar.2018.11.029.", "ArticleIdList": ["10.1016/j.ejphar.2018.11.029", "30481497"]}, {"Citation": "Vuolo F., Petronilho F., Sonai B., Ritter C., Hallak J.E., Zuardi A.W., Crippa J.A., Dal-Pizzol F. Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma. Mediat. Inflamm. 2015;2015:538670. doi: 10.1155/2015/538670.", "ArticleIdList": ["10.1155/2015/538670", "PMC4458548", "26101464"]}, {"Citation": "Kaplan B.L., Springs A.E., Kaminski N.E. The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT) Biochem. Pharm. 2008;76:726\u2013737. doi: 10.1016/j.bcp.2008.06.022.", "ArticleIdList": ["10.1016/j.bcp.2008.06.022", "PMC2748879", "18656454"]}, {"Citation": "Khodadadi H., Salles \u00c9.L., Jarrahi A., Chibane F., Costigliola V., Yu J.C., Vaibhav K., Hess D.C., Dhandapani K.M., Baban B. Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA. Cannabis Cannabinoid Res. 2020;5:197\u2013201. doi: 10.1089/can.2020.0043.", "ArticleIdList": ["10.1089/can.2020.0043", "PMC7480719", "32923657"]}, {"Citation": "Khodadadi H., Salles \u00c9.L., Shin E., Jarrahi A., Costigliola V., Kumar P., Yu J.C., Morgan J.C., Hess D.C., Vaibhav K., et al. A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome. J. Cannabis. Res. 2021;3:45. doi: 10.1186/s42238-021-00101-0.", "ArticleIdList": ["10.1186/s42238-021-00101-0", "PMC8485768", "34598736"]}, {"Citation": "Milam J.E., Keshamouni V.G., Phan S.H., Hu B., Gangireddy S.R., Hogaboam C.M., Standiford T.J., Thannickal V.J., Reddy R.C. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008;294:L891\u2013L901. doi: 10.1152/ajplung.00333.2007.", "ArticleIdList": ["10.1152/ajplung.00333.2007", "PMC5926773", "18162602"]}, {"Citation": "Huang Y., Wan T., Pang N., Zhou Y., Jiang X., Li B., Gu Y., Huang Y., Ye X., Lian H., et al. Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-\u03baB and NLRP3 inflammasome pathway. J. Cell. Physiol. 2019;234:21224\u201321234. doi: 10.1002/jcp.28728.", "ArticleIdList": ["10.1002/jcp.28728", "31032942"]}, {"Citation": "Ribeiro A., Almeida V.I., Costola-de-Souza C., Ferraz-de-Paula V., Pinheiro M.L., Vitoretti L.B., Gimenes-Junior J.A., Akamine A.T., Crippa J.A., Tavares-de-Lima W., et al. Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury. Immunopharmacol. Immunotoxicol. 2015;37:35\u201341. doi: 10.3109/08923973.2014.976794.", "ArticleIdList": ["10.3109/08923973.2014.976794", "25356537"]}, {"Citation": "Ribeiro A., Ferraz-de-Paula V., Pinheiro M.L., Vitoretti L.B., Mariano-Souza D.P., Quinteiro-Filho W.M., Akamine A.T., Almeida V.I., Quevedo J., Dal-Pizzol F., et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor. Eur. J. Pharmacol. 2012;678:78\u201385. doi: 10.1016/j.ejphar.2011.12.043.", "ArticleIdList": ["10.1016/j.ejphar.2011.12.043", "22265864"]}, {"Citation": "Sadowska O., Baranowska-Kuczko M., Gromotowicz-Pop\u0142awska A., Biernacki M., Kicman A., Malinowska B., Kasacka I., Krzy\u017cewska A., Koz\u0142owska H. Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats. Int. J. Mol. Sci. 2020;21:7077. doi: 10.3390/ijms21197077.", "ArticleIdList": ["10.3390/ijms21197077", "PMC7582795", "32992900"]}, {"Citation": "Arruza L., Pazos M.R., Mohammed N., Escribano N., Lafuente H., Santos M., Alvarez-D\u00edaz F.J., Hind W., Mart\u00ednez-Orgado J. Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets. Pediatr. Res. 2017;82:79\u201386. doi: 10.1038/pr.2017.104.", "ArticleIdList": ["10.1038/pr.2017.104", "28388598"]}, {"Citation": "Crippa J.A.S., Pacheco J.C., Zuardi A.W., Guimar\u00e3es F.S., Campos A.C., Os\u00f3rio F.L., Loureiro S.R., Dos Santos R.G., Souza J.D.S., Ushirohira J.M., et al. Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cannabis Cannabinoid Res. 2021;7:658\u2013669. doi: 10.1089/can.2021.0093.", "ArticleIdList": ["10.1089/can.2021.0093", "PMC9587798", "34619044"]}, {"Citation": "Whittaker A., Anson M., Harky A. Neurological Manifestations of COVID-19: A systematic review and current update. Acta Neurol. Scand. 2020;142:14\u201322. doi: 10.1111/ane.13266.", "ArticleIdList": ["10.1111/ane.13266", "PMC7273036", "32412088"]}, {"Citation": "Krizinger A.K.A., Hamel L., Brodie M. KFF Health Follow-up Survey\u2014Early April 2020: The Impact of Coronavirus on Life in the United States.  [(accessed on 10 August 2022)].  Available online:  https://www.kff.org/coronavirus-covid-19/report/kff-health-tracking-poll-early-april-2020/"}, {"Citation": "Fiani B., Sarhadi K.J., Soula M., Zafar A., Quadri S.A. Current application of cannabidiol (CBD) in the management and treatment of neurological disorders. Neurol. Sci. 2020;41:3085\u20133098. doi: 10.1007/s10072-020-04514-2.", "ArticleIdList": ["10.1007/s10072-020-04514-2", "32556748"]}, {"Citation": "McPartland J.M., Glass M., Pertwee R.G. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: Interspecies differences. Br. J. Pharm. 2007;152:583\u2013593. doi: 10.1038/sj.bjp.0707399.", "ArticleIdList": ["10.1038/sj.bjp.0707399", "PMC2190026", "17641667"]}, {"Citation": "Breivogel C.S., Sim-Selley L.J. Basic neuroanatomy and neuropharmacology of cannabinoids. Int. Rev. Psychiatry. 2009;21:113\u2013121. doi: 10.1080/09540260902782760.", "ArticleIdList": ["10.1080/09540260902782760", "19367505"]}, {"Citation": "Pazos M.R., N\u00fa\u00f1ez E., Benito C., Tol\u00f3n R.M., Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacol. Biochem. Behav. 2005;81:239\u2013247. doi: 10.1016/j.pbb.2005.01.030.", "ArticleIdList": ["10.1016/j.pbb.2005.01.030", "15936805"]}, {"Citation": "Neumeister A., Normandin M.D., Pietrzak R.H., Piomelli D., Zheng M.Q., Gujarro-Anton A., Potenza M.N., Bailey C.R., Lin S.F., Najafzadeh S., et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study. Mol. Psychiatry. 2013;18:1034\u20131040. doi: 10.1038/mp.2013.61.", "ArticleIdList": ["10.1038/mp.2013.61", "PMC3752332", "23670490"]}, {"Citation": "Thibaut F., van Wijngaarden-Cremers P.J.M. Women\u2019s Mental Health in the Time of COVID-19 Pandemic. Front. Glob. Women's Health. 2020;1:588372. doi: 10.3389/fgwh.2020.588372.", "ArticleIdList": ["10.3389/fgwh.2020.588372", "PMC8593968", "34816164"]}, {"Citation": "Yan S., Xu R., Stratton T.D., Kavcic V., Luo D., Hou F., Bi F., Jiao R., Song K., Jiang Y. Sex differences and psychological stress: Responses to the COVID-19 pandemic in China. BMC Public Health. 2021;21:79. doi: 10.1186/s12889-020-10085-w.", "ArticleIdList": ["10.1186/s12889-020-10085-w", "PMC7789895", "33413224"]}, {"Citation": "Solowij N., Broyd S.J., Beale C., Prick J.A., Greenwood L.M., van Hell H., Suo C., Galettis P., Pai N., Fu S., et al. Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial. Cannabis Cannabinoid Res. 2018;3:21\u201334. doi: 10.1089/can.2017.0043.", "ArticleIdList": ["10.1089/can.2017.0043", "PMC5870061", "29607408"]}, {"Citation": "Crippa J.A., Zuardi A.W., Garrido G.E., Wichert-Ana L., Guarnieri R., Ferrari L., Azevedo-Marques P.M., Hallak J.E., McGuire P.K., Filho Busatto G. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004;29:417\u2013426. doi: 10.1038/sj.npp.1300340.", "ArticleIdList": ["10.1038/sj.npp.1300340", "14583744"]}, {"Citation": "Zuardi A.W., Cosme R.A., Graeff F.G., Guimar\u00e3es F.S. Effects of ipsapirone and cannabidiol on human experimental anxiety. J. Psychopharmacol. 1993;7:82\u201388. doi: 10.1177/026988119300700112.", "ArticleIdList": ["10.1177/026988119300700112", "22290374"]}, {"Citation": "Zuardi A.W., Rodrigues N.P., Silva A.L., Bernardo S.A., Hallak J.E.C., Guimar\u00e3es F.S., Crippa J.A.S. Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life. Front. Pharmacol. 2017;8:259. doi: 10.3389/fphar.2017.00259.", "ArticleIdList": ["10.3389/fphar.2017.00259", "PMC5425583", "28553229"]}, {"Citation": "Bergamaschi M.M., Queiroz R.H., Chagas M.H., de Oliveira D.C., De Martinis B.S., Kapczinski F., Quevedo J., Roesler R., Schr\u00f6der N., Nardi A.E., et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients. Neuropsychopharmacology. 2011;36:1219\u20131226. doi: 10.1038/npp.2011.6.", "ArticleIdList": ["10.1038/npp.2011.6", "PMC3079847", "21307846"]}, {"Citation": "Crippa J.A., Derenusson G.N., Ferrari T.B., Wichert-Ana L., Duran F.L., Martin-Santos R., Sim\u00f5es M.V., Bhattacharyya S., Fusar-Poli P., Atakan Z., et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report. J. Psychopharmacol. 2011;25:121\u2013130. doi: 10.1177/0269881110379283.", "ArticleIdList": ["10.1177/0269881110379283", "20829306"]}, {"Citation": "Elms L., Shannon S., Hughes S., Lewis N. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. J. Altern. Complement. Med. 2019;25:392\u2013397. doi: 10.1089/acm.2018.0437.", "ArticleIdList": ["10.1089/acm.2018.0437", "PMC6482919", "30543451"]}, {"Citation": "Shannon S., Lewis N., Lee H., Hughes S. Cannabidiol in anxiety and sleep: A large case series. Perm. J. 2019;23:18\u201341. doi: 10.7812/TPP/18-041.", "ArticleIdList": ["10.7812/TPP/18-041", "PMC6326553", "30624194"]}, {"Citation": "Appiah-Kusi E., Petros N., Wilson R., Colizzi M., Bossong M.G., Valmaggia L., Mondelli V., McGuire P., Bhattacharyya S. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis. Psychopharmacology. 2020;237:1121\u20131130. doi: 10.1007/s00213-019-05442-6.", "ArticleIdList": ["10.1007/s00213-019-05442-6", "PMC7113209", "31915861"]}, {"Citation": "Wilson R., Bossong M.G., Appiah-Kusi E., Petros N., Brammer M., Perez J., Allen P., McGuire P., Bhattacharyya S. Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis. Transl. Psychiatry. 2019;9:203. doi: 10.1038/s41398-019-0534-2.", "ArticleIdList": ["10.1038/s41398-019-0534-2", "PMC6706374", "31439831"]}, {"Citation": "Crippa J.A.S., Zuardi A.W., Guimar\u00e3es F.S., Campos A.C., de Lima Os\u00f3rio F., Loureiro S.R., Dos Santos R.G., Souza J.D.S., Ushirohira J.M., Pacheco J.C., et al. Efficacy and Safety of Cannabidiol Plus Standard Care vs. Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw. Open. 2021;4:e2120603. doi: 10.1001/jamanetworkopen.2021.20603.", "ArticleIdList": ["10.1001/jamanetworkopen.2021.20603", "PMC8363917", "34387679"]}, {"Citation": "Murillo-Rodr\u00edguez E., Mill\u00e1n-Aldaco D., Palomero-Rivero M., Mechoulam R., Drucker-Col\u00edn R. The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent. Behav. Neurosci. 2008;122:1378\u20131382. doi: 10.1037/a0013278.", "ArticleIdList": ["10.1037/a0013278", "19045957"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "7"}, {"Year": "2022", "Month": "12", "Day": "1"}, {"Year": "2022", "Month": "12", "Day": "6"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "1", "Minute": "40"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["36556483", "PMC9784976", "10.3390/life12122117", "life12122117"]}}], "PubmedBookArticle": []}